Sprint Bioscience: Replacing Decipher as a VPS34 partner - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Sprint Bioscience: Replacing Decipher as a VPS34 partner - Redeye

{newsItem.title}

Sprint Bioscience is looking to replace Decipher as a partner for VPS34 as soon as the project is handed back. Decipher’s decision follows four month after securing Day One as a partner for VADA. We have made an early revision where the main change is a 15-24 months delay for the VPS34 project. We point to upcoming triggers relating to VADA and NASH. We adjust our base case to SEK3.2 (SEK3.9).

Länk till analysen i sin helhet: https://www.redeye.se/research/969117/sprint-bioscience-replacing-decipher-as-a-vps34-partner?utm_source=finwire&utm_medium=RSS

Nyheter om Sprint Bioscience

Läses av andra just nu

Om aktien Sprint Bioscience

Senaste nytt